![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 15125 |
FusionGeneSummary for GP2_LYZ |
![]() |
Fusion gene information | Fusion gene name: GP2_LYZ | Fusion gene ID: 15125 | Hgene | Tgene | Gene symbol | GP2 | LYZ | Gene ID | 2813 | 4069 |
Gene name | glycoprotein 2 | lysozyme | |
Synonyms | ZAP75 | LYZF1|LZM | |
Cytomap | 16p12.3 | 12q15 | |
Type of gene | protein-coding | protein-coding | |
Description | pancreatic secretory granule membrane major glycoprotein GP2glycoprotein 2 (zymogen granule membrane)pancreatic zymogen granule membrane associated protein GP2 | lysozyme C1,4-beta-N-acetylmuramidase Cc-type lysozymelysozyme F1 | |
Modification date | 20180522 | 20180523 | |
UniProtAcc | P55259 | P61626 | |
Ensembl transtripts involved in fusion gene | ENST00000302555, ENST00000381362, ENST00000341642, ENST00000381360, ENST00000573897, | ENST00000261267, ENST00000549690, ENST00000548839, | |
Fusion gene scores | * DoF score | 1 X 2 X 1=2 | 26 X 11 X 9=2574 |
# samples | 2 | 30 | |
** MAII score | log2(2/2*10)=3.32192809488736 | log2(30/2574*10)=-3.10097764772482 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: GP2 [Title/Abstract] AND LYZ [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | LYZ | GO:0031640 | killing of cells of other organism | 9727055 |
Tgene | LYZ | GO:0042742 | defense response to bacterium | 21093056 |
Tgene | LYZ | GO:0050830 | defense response to Gram-positive bacterium | 21093056 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | STAD | TCGA-HF-7132-01A | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
TCGA | LD | STAD | TCGA-VQ-A8PC-01A | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3UTR | ENST00000302555 | ENST00000261267 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000302555 | ENST00000549690 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000302555 | ENST00000548839 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-3UTR | ENST00000381362 | ENST00000261267 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000381362 | ENST00000549690 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000381362 | ENST00000548839 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-3UTR | ENST00000341642 | ENST00000261267 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000341642 | ENST00000549690 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000341642 | ENST00000548839 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-3UTR | ENST00000381360 | ENST00000261267 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000381360 | ENST00000549690 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000381360 | ENST00000548839 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-3UTR | ENST00000573897 | ENST00000261267 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000573897 | ENST00000549690 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000573897 | ENST00000548839 | GP2 | chr16 | 20322470 | - | LYZ | chr12 | 69747553 | + |
intron-3UTR | ENST00000302555 | ENST00000261267 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000302555 | ENST00000549690 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000302555 | ENST00000548839 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-3UTR | ENST00000381362 | ENST00000261267 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000381362 | ENST00000549690 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000381362 | ENST00000548839 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-3UTR | ENST00000341642 | ENST00000261267 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000341642 | ENST00000549690 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000341642 | ENST00000548839 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-3UTR | ENST00000381360 | ENST00000261267 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000381360 | ENST00000549690 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000381360 | ENST00000548839 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-3UTR | ENST00000573897 | ENST00000261267 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000573897 | ENST00000549690 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
intron-intron | ENST00000573897 | ENST00000548839 | GP2 | chr16 | 20322540 | - | LYZ | chr12 | 69747553 | + |
Top |
FusionProtFeatures for GP2_LYZ |
![]() |
Hgene | Tgene |
GP2 | LYZ |
Lysozymes have primarily a bacteriolytic function; thosein tissues and body fluids are associated with the monocyte-macrophage system and enhance the activity of immunoagents. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for GP2_LYZ |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for GP2_LYZ |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
GP2 | SOX30, TSSK3, GLP1R | LYZ | KHK, LRRK1, NME2, LTF, PARP11, USP1, USP25, CUL4B, CDK2, COPS6, CLU, GRK5, CRK, SMAD6, STAU1, AURKA, CEP57, NEDD1, TP53, FUS, RPS6KB2, NTRK1, MCM2, CRYAB, DDX31, FRMD1, HBM, SNX27, WWOX, CYLD, CDK1, TRIM25 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for GP2_LYZ |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for GP2_LYZ |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | GP2 | C0005910 | Body Weight | 1 | CTD_human |
Tgene | LYZ | C0268389 | Amyloidosis, familial visceral | 1 | CTD_human;UNIPROT |